Summer clinical institute in addiction studies
David Deitch, PhD, is the Founder of the Center for Criminality and Addiction Research, Training
and Application (CCARTA) at the currently Emeritus Professor of Clinical Psychiatry at the
University of California, San Diego. Dr. Deitch has over 45 years of experience in the development of drug abuse treatment systems for adolescents and adults, nationally and internationally. In the non-profit public health sector, he was Co-Founder of Daytop Village, Inc., and also served as Senior Vice President and Chief Clinical Officer for Phoenix House’s Foundation. In the academic sector, he has had appointments at Temple University, the University of Chicago, University of California at San Francisco, as well as serving as Chief of Substance Abuse Services for the University of California, San Francisco. In the government sector, he has served as Coordinator of Curriculum and Faculty for the United Nations East Central European Drug Abuse Treatment Training Project; has consulted to a variety of Department of Corrections and Ministries of Justice and Health, in Latin America, SE Asia and Europe. Dr. Deitch served during the Johnson Administration as consultant to the Presidential Commission for the Study of Crime and Juvenile Delinquency, and the National Commission on Marijuana and Drug Abuse. During the Carter Administration, he chaired the White House Task Force on Prevention. He chaired the Curriculum Development Committee of the National Addiction Technology Transfer Centers, Technical Assistance Publication Series 21 — The Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice, used today as a guideline for corrections and community based substance abuse treatment organizations. He has further served as Regional Director of the Executive Committee of the Association for Medical Education and Research in Substance Abuse — Mentor Project (2000). He has numerous publications (and videos) in the field.
Igor Koutsenok, MD, MS is а Professor of Practice in Psychiatry at the University of California San Diego, Director of the Center for Criminality and Addiction Research, Training and Application, Director of the SAMHSA Addiction Technology Transfer Center-Ukraine. He graduated as a medical doctor in 1983 at the National Medical University in Kiev, (Ukraine). In 1986, he completed his psychiatry residency training and received degree as psychiatrist from the Medical University in Sofia (Bulgaria). In 1993 -1996 he worked at the University of London, Department of Addictive Behavior and Psychological Medicine at St. Georges Hospital Medical School and completed Masters Degree in Addictive Behavior. In 1996, he was recruited by the University of California San Diego, School of Medicine, Department of Psychiatry and since then he serves as faculty member of the Department. In 2013-2016 he served as Chief of Prevention, Treatment, and Rehabilitation Branch at the United Nations Office on Drugs and Crime, United Nations Office in Vienna. Over the last 20 years Dr. Koutsenok led the design and implementation of multiple training and technical assistance programs for addiction treatment, mental health practitioners, primary health care and social work practitioners, criminal justice professionals in the United States and around the world. Dr. Koutsenok served as a trainer for the National Drug Court Institute in the USA. Dr. Koutsenok is also a member of the International Motivational Interviewing Network of Trainers (MINT). For many years, Dr. Koutsenok teaches general and addiction psychiatry to medical students, psychiatry residents, psychology trainees, social workers, criminal justice professionals, and policy makers around the world. He is a recipient of numerous national and international awards. He has authored and co-authored over 30 scientific publications and 4 book chapters. Dr. Koutsenok has been invited as a presenter and trainer to hundreds of conferences and workshops in the USA and more than 40 countries around the world. He is a proud father of three.
2021 UCSD SCI Distinguished Faculty
Kathleen Allison was appointed by Governor Gavin Newsom as Secretary for the California Department of Corrections and Rehabilitation (CDCR) on October 1, 2020. In her over 30 years at CDCR, she has held several leadership roles, including most recently Undersecretary of Operations. Prior to that, she was Director of the Division of Adult Institutions (DAI) from 2016 to 2018; Deputy Director of Facility Support from 2012 to 2016; and Associate Director for the Female Offender Programs and Services from 2011 to 2012. Ms. Allison also served in several positions at the California Substance Abuse Treatment Facility in Corcoran from 2002 to 2011, including Warden; Chief Deputy Administrator; Correctional Administrator; and Correctional Health Services Administrator II. She also held several positions at Avenal State Prison from 1987 to 2002, including Community Resources Manager and Senior Medical Technical Assistant. Ms. Allison began her career as a Medical Technical Assistant at Avenal State Prison in 1987. She is a licensed Registered Nurse.
Ms. Allison has experienced nearly all aspects of corrections in her tenure at CDCR, from health care and custody operations, to fiscal administration, rehabilitative programs, mental health services, and community relationships. Most recently as Undersecretary, she has been critical in the response of CDCR to the COVID-19 pandemic in some of the state’s 35 prisons. Those efforts have included the suspension of intake, visiting and volunteering, the expedited release of eligible inmates, the reduction of the prison population to its lowest level in 30 years, and the response to the outbreak in San Quentin State Prison.
Additionally, Ms. Allison has overseen the evolution of the Department over the past three decades, including the implementation of various criminal justice reforms, such as the voter-approved initiatives Proposition 36, Proposition 47, and Proposition 57. She has also successfully led the development of policies and programs that focus on rehabilitation, restorative justice, and successful reentry, which have made prisons safer for staff and incarcerated people, and has strengthened partnerships with both governmental agencies and community organizations to create a system focused on public safety, personal accountability, and positive change.
Ms. Allison is known to her colleagues as a dedicated, compassionate and knowledgeable leader. She is married, has four children, and has a Tibetan terrier.
Christopher Blazes, M.D., is a board-certified addiction psychiatrist at U-M Addiction Treatment Services, as well as an emergency medicine physician at U-M Hospital. Dr. Blazes has been a board certified emergency medicine physician for over 17 years, and his work serves as a bridge between emergency medicine and psychiatry. Dr. Blazes specializes in providing pharmacologic treatment for addiction and co-occurring disorders, as well as in other non-traditional methods to addiction treatment, including mindfulness practices and techniques. His treatments are highly individualized, and based on the unique needs of each patient.
Dr. Blazes received his M.D. from the University of Rochester School of Medicine and Dentistry, and his emergency medicine training at Brown University School of Medicine. Dr. Blazes has received many honors and awards. His most recent awards include the 2017 Laughlin Award for Outstanding Psychiatry Resident and the 2017 Menin Humanistic Sensitivity Award.
His research interests include developing a better understanding of the morbidities and mortality associated with benzodiazepine use, enhanced management for the process of de-prescribing benzodiazepines, as well as management of the postacute withdrawal syndrome associated with chronic benzodiazepine use. He is also involved in regional, state and national efforts to initiate addiction treatments for at risk patients from the emergency department.
Brantley Choate, Ph.D. has been reappointed director of the Division of Rehabilitative Programs at the CDCR, where he has served as director of the Division of Rehabilitative Programs since 2017. Since 2003, Choate worked in the field of adult education
managing both California adult schools as well as university programs. He was the Director of Inmate Education for the Los Angeles County Sheriff’s Department from 2011 to 2014.
From 2014 to 2017, Choate served as California’s State Superintendent of Correctional Education leading academic, career technical education, and college programs for all 35 state prisons. Choate holds a Bachelor of Science degree from Brigham Young University in Educational Psychology and a Master’s and Doctorate from Saint Mary’s College of California in Educational Leadership. Choate was confirmed to this position by the California Senate in 2018.
Thom Browne, Jr., MA Rubicon Global Enterprises: President and CEO (Aug. 2015 – present) Colombo Plan Secretariat: Chief Executive Officer (Jan. 2016 – present) Provides global technical assistance on drug prevention, treatment, recovery, and criminal justice issues. Chairs international working groups to develop certification for addictions counselors, licensing for treatment centers, and networks of treatment/prevention professionals. Serves as expert advisor to selected international organizations on counter-narcotics issues. Develops specialized programs addressing unique international challenges such as identification of toxic adulterants added to drugs of abuse and related public health responses. Developed the U.S. government's program and approach to international drug demand reduction for over 25 years as the U.S. Department of State's Division Director for Criminal Justice Programs.
Zafiris J. Daskalakis, MD, Ph.D. is a Professor and Chair of the Department of Psychiatry at the UC San Diego. He was formerly the Temerty Chair in Therapeutic Brain Intervention and Chief of the Mood and Anxiety Division at CAMH. His research involves the use of magnetic brain stimulation to study the role of cortical inhibition, plasticity and connectivity as potential pathophysiological mechanisms in schizophrenia, depression and obsessive compulsive disorder. Dr. Daskalakis also conducts treatment studies using repetitive transcranial magnetic brain stimulation (rTMS), magnetic seizure therapy (MST) and electroconvulsive therapy (ECT) for resistant symptoms in these disorders. He has received several national and international awards and distinctions including the Samarthji Lal Award in Mental Health Research from the Graham Boeckh Foundation for the top mid-career neuropsychopharmacology researcher in Canada in 2013. He also holds or has held NIMH and CIHR peer-reviewed funding and has also mentored numerous NARSAD Young Investigator awardees. Finally, he has over 400 peer-reviewed publications, books and book chapters and is an editorial board member for Biological Psychiatry and an Associate Editor for Clinical Neurophysiology.
J. Randy Koch, Ph.D. is an associate professor in the Department of Psychology at Virginia Commonwealth University.
Dr. Koch earned his doctorate in community psychology from Michigan State University in 1985. Prior to joining VCU in 2003, he was the Director of Research and Evaluation for the Virginia Department of Behavioral Health and Developmental Services, a position he held since 1989. In this position, he was responsible for evaluating publicly-funded behavioral healthcare services in Virginia as well as conducting a wide range of policy studies. Since joining VCU, his research interests have focused primarily on the prevention of youth tobacco use and methods for improving the quality of substance abuse services especially program performance and outcome measurement. Among his current responsibilities, he is a Co-PI for the Virginia Youth Tobacco Projects, a statewide, multi-university research program on the causes and prevention of youth tobacco use; he is a co-investigator for a study assessing the impact of alternative tobacco control policies on youth tobacco use; and he is the director of the VCU Humphrey Fellowship Program on Substance Abuse Prevention, Treatment, and Policy that brings mid-career professionals from low and middle-income countries to VCU for advanced leadership and technical training. Dr. Koch’s international work includes serving as a peer reviewer for the ISSUP Universal Treatment Curriculum, serving on the project team developing an international set of standards and quality assurance protocols for drug treatment services, and co-developing a performance and outcome measurement system for South Africa’s addiction treatment services.
Douglas B. Marlowe, JD, Ph.D., is a Senior Scientific Consultant for the National Association of Drug Court Professionals (NADCP) and Senior Science & Policy Advisor for Alcohol Monitoring Systems. Previously, he was the Chief of Science, Law & Policy for NADCP, the Director of Law & Ethics Research at the Treatment Research Institute, and Adjunct Associate Professor of Psychiatry at the University of Pennsylvania School of Medicine.
A lawyer and clinical psychologist, Dr. Marlowe studies the impact of coercion in substance use treatment, the effects of drug courts and other rehabilitation programs for persons with substance use disorders involved in the justice system, and behavioral treatments for persons with substance use disorders and justice system involvement. He is a Fellow of the American Psychological Association (APA) and the College of Physicians of Philadelphia, has received proficiency certification in the treatment of psychoactive substance use disorders from the APA College of Professional Psychology, and is a designated Master Addiction Counselor by the National Certification Commission for Addiction Professionals.
Dr. Marlowe has published over 175 journal articles, monographs, books, and book chapters on the topics of correctional rehabilitation, forensic psychology, and treatment of substance use disorders. He is the Editor-in-Chief of the Journal for Advancing Justice, serves on the editorial boards of Criminal Justice & Behavior and the Drug Court Review, and was previously the Editor-in-Chief of the Drug Court Review.
Brian Morales, MA is the Chief of the Counternarcotics Branch at the U.S. Department of State’s Bureau of International Narcotics and Law Enforcement Affairs (INL). He has worked on the issue of drug demand reduction for 13 years, covering programs throughout the world. One of his most notable achievements was the establishment of the International Society of Substance Use Prevention and Treatment Professionals (ISSUP) in July 2015, bringing together the global treatment and prevention workforce into an association that promotes professionalization through training and credentialing. In March 2016, he collaborated with international partners to launch the International Consortium of Universities for Drug Demand Reduction (ICUDDR) to promote academic study around the world in the field of addiction science. Prior to this post, Brian covered Afghanistan counternarcotics issues and also served in the Bureau of Western Hemisphere Affairs at the U.S. Mission to the Organization of American States. Brian earned his Bachelor of Science in Foreign Service (2001) and a Master of Arts in Latin American Studies (2004), both from Georgetown University.
Renee Kanan, MD, MPH
Marc A. Schuckit, MD, is Professor of Psychiatry and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA San Diego Healthcare System. Dr. Schuckit received his BS from the University of Wisconsin, an MD from Washington University, interned at Cedars Sinai Medical Center, and was a resident in psychiatry at Washington University and UCSD. He was a special advisor to the Commanding Officer of the Naval Health Research Center, and the first Director of the Alcohol and Drug Institute, University of Washington (1975-1978). He returned to San Diego as Professor and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA San Diego Healthcare System. Dr. Schuckit’s major focus is alcohol and drugs. He was Chair of the DSM-IV substance disorders workgroup and has published papers about the optimal diagnostic criteria for substance use disorders. Regarding the genetics of alcoholism, he has carried out adoption studies, identified a genetic characteristic that impacts on elevated alcoholism risk (the low level of response to alcohol), and is now searching for related genes. He is currently completing a 20-year follow-up (97% success rate) of sons of alcoholics where he is trying to identify environmental events that might relate to whether biological predisposition toward alcohol dependence is expressed. An additional research area is co-morbidity between substance use disorders and major psychiatric conditions.
Dr. Schuckit directed the Alcohol and Drug Treatment Program at the VA San Diego Healthcare System, supervising residents, medical students and staff. He is also a major contact person regarding alcohol and drug problems in faculty and staff at UCSD and the San Diego VA. Additional clinical interests include the treatment of depressive disorders, anxiety conditions, and geriatric psychiatric populations.
Jon Stiffler, MD graduated with a Bachelor of Science in biochemistry and molecular biology from The Pennsylvania State
University and received his M.D. from The Pennsylvania State University College of Medicine in 2010. After completing residency training at New York University where he was chief resident, he went on to complete a fellowship in Addiction Psychiatry at New
York University. Dr. Stiffler is currently an HS Clinical Assistant Professor at the University of California at San Diego and is the
Associate Director of the Addiction Psychiatry Fellowship Program. He remains on faculty at the New York University School of Medicine where he is an Adjunct Assistant Professor of Psychiatry. He is board certified in General Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology.